$71.41
0.55% yesterday
Nasdaq, May 20, 09:50 pm CET
ISIN
US81663L1017
Symbol
WGS

Sema4 Holdings Corp - Ordinary Shares - Class A Stock price

$72.11
-18.93 20.79% 1M
+2.73 3.93% 6M
-4.75 6.18% YTD
+50.35 231.39% 1Y
+8.42 13.22% 3Y
-251.29 77.70% 5Y
-251.29 77.70% 10Y
Nasdaq, Closing price Tue, May 20 2025
+1.09 1.53%
ISIN
US81663L1017
Symbol
WGS

Key metrics

Market capitalization $2.06b
Enterprise Value $2.01b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 6.10
P/S ratio (TTM) P/S ratio 6.23
P/B ratio (TTM) P/B ratio 7.99
Revenue growth (TTM) Revenue growth 48.81%
Revenue (TTM) Revenue $330.14m
EBIT (operating result TTM) EBIT $-12.64m
Free Cash Flow (TTM) Free Cash Flow $-13.08m
Cash position $159.16m
EPS (TTM) EPS $-1.44
P/E forward negative
P/S forward 5.58
EV/Sales forward 5.46
Short interest 25.27%
Show more

Is Sema4 Holdings Corp - Ordinary Shares - Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Sema4 Holdings Corp - Ordinary Shares - Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Sema4 Holdings Corp - Ordinary Shares - Class A forecast:

5x Buy
71%
2x Hold
29%

Analyst Opinions

7 Analysts have issued a Sema4 Holdings Corp - Ordinary Shares - Class A forecast:

Buy
71%
Hold
29%

Financial data from Sema4 Holdings Corp - Ordinary Shares - Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
330 330
49% 49%
100%
- Direct Costs 129 129
5% 5%
39%
201 201
132% 132%
61%
- Selling and Administrative Expenses 145 145
16% 16%
44%
- Research and Development Expense 46 46
5% 5%
14%
10 10
112% 112%
3%
- Depreciation and Amortization 23 23
29% 29%
7%
EBIT (Operating Income) EBIT -13 -13
89% 89%
-4%
Net Profit -39 -39
71% 71%
-12%

In millions USD.

Don't miss a Thing! We will send you all news about Sema4 Holdings Corp - Ordinary Shares - Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sema4 Holdings Corp - Ordinary Shares - Class A Stock News

Positive
Seeking Alpha
about 18 hours ago
GeneDx delivered strong Q1 2025 results, beating revenue and EPS estimates, and raised full-year guidance despite a minor sequential test volume dip. The volume decline is attributable to seasonality, adverse weather, and one fewer business day, not a structural slowdown; fundamentals remain robust. Strong pricing power and rising reimbursement rates drive revenue growth, setting a solid founda...
Neutral
Investors Business Daily
one day ago
The top five biotech stocks today have several commonalities. Among them are strong ratings.
Positive
Seeking Alpha
7 days ago
GeneDx's recent 50% stock drop post-Q1 earnings is seen as an overreaction, despite a projected modest growth slowdown from 42% to 30-35%. The company is expanding product lines, improving margins, and increasing insurance coverage, with the recent acquisition of Fabric Genomics offering growth and cost synergies. GeneDx's valuation is attractive compared to peers, with a forward P/E of 30 and ...
More Sema4 Holdings Corp - Ordinary Shares - Class A News

Company Profile

Sema4 Holdings Corp.is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm through its Centrellis health intelligence platform enables to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in 2016 and is headquartered in Stamford, CT.

Head office United States
CEO Katherine Stueland
Employees 1,000
Founded 2015
Website www.genedx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today